Literature DB >> 24821231

[Medical University of Vienna researcher of the month, May 2014].

Barbara Kiesewetter1.   

Abstract

Mesh：

Year:  2014        PMID： 24821231     DOI： 10.1007/s00508-014-0562-0

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN： 0043-5325            Impact factor:   1.704


× No keyword cloud information.
  9 in total

1.  Primary mucosa-associated lymphoid tissue (MALT) lymphoma of the liver: clinical, molecular, and microbiological aspects.

Authors:  Barbara Kiesewetter; Leonhard Müllauer; Berthold Streubel; Hermine Agis; Alexander Hirschl; Athanasios Makristathis; Markus Raderer
Journal:  Ann Hematol       Date:  2012-04-04       Impact factor: 3.673

2.  Ondansetron for diarrhea associated with neuroendocrine tumors.

Authors:  Barbara Kiesewetter; Markus Raderer
Journal:  N Engl J Med       Date:  2013-05-16       Impact factor: 91.245

3.  Plasmacytic differentiation in MALT lymphomas following treatment with rituximab.

Authors:  Marlene Troch; Barbara Kiesewetter; Werner Dolak; Ulrich Jaeger; Andreas Püspök; Leonhard Müllauer; Andreas Chott; Markus Raderer
Journal:  Ann Hematol       Date:  2011-12-22       Impact factor: 3.673

4.  Subcutaneous dissemination pattern in extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue lymphoma.

Authors:  Constanze Jonak; Marlene Troch; Barbara Kiesewetter; Julius Lukas; Leonhard Müllauer; Ulrich Jäger; Andreas Chott; Markus Raderer
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

5.  A phase II study of lenalidomide in patients with extranodal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT lymphoma).

Authors:  Barbara Kiesewetter; Marlene Troch; Werner Dolak; Leonhard Müllauer; Julius Lukas; Christoph C Zielinski; Markus Raderer
Journal:  Haematologica       Date:  2012-08-16       Impact factor: 9.941

6.  Second line chemotherapy in patients with enteropathy-associated T cell lymphoma: a retrospective single center analysis.

Authors:  Markus Raderer; Marlene Troch; Barbara Kiesewetter; Andreas Püspök; Ulrich Jaeger; Martha Hoffmann; Andreas Chott
Journal:  Ann Hematol       Date:  2011-04-26       Impact factor: 3.673

Review 7.  Antibiotic therapy in nongastrointestinal MALT lymphoma: a review of the literature.

Authors:  Barbara Kiesewetter; Markus Raderer
Journal:  Blood       Date:  2013-06-14       Impact factor: 22.113

8.  Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentose Tumortherapie.

Authors:  Marlene Troch; Barbara Kiesewetter; Wolfgang Willenbacher; Ella Willenbacher; Armin Zebisch; Werner Linkesch; Michael Fridrik; Leonhard Müllauer; Richard Greil; Markus Raderer
Journal:  Haematologica       Date:  2012-09-14       Impact factor: 9.941

9.  Rituximab plus bendamustine is active in pretreated patients with extragastric marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma).

Authors:  Barbara Kiesewetter; Marius E Mayerhoefer; Julius Lukas; Christoph C Zielinski; Leonhard Müllauer; Markus Raderer
Journal:  Ann Hematol       Date:  2013-08-08       Impact factor: 3.673
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.